SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-015476
Filing Date
2018-11-13
Accepted
2018-11-13 15:39:29
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0918_relmadatherap.htm 10-Q 409208
2 FORM OF 2018 WARRANT f10q0918ex4-1_relmadatherap.htm EX-4.1 76573
3 UNIT PURCHASE AGREEMENT, DATED AS OF OCTOBER 12 AND 18, 2018, AND NOVEMBER 2, 20 f10q0918ex10-1_relmadatherap.htm EX-10.1 229452
4 SUBSCRIPTION AGREEMENT, DATED AS OF OCTOBER 12 AND 18, 2018, AND NOVEMBER 2, 201 f10q0918ex10-2_relmadatherap.htm EX-10.2 196193
5 REGISTRATION RIGHTS AGREEMENT, DATED AS OF OCTOBER 12 AND 18, 2018, AND NOVEMBER f10q0918ex10-3_relmadatherap.htm EX-10.3 140765
6 CERTIFICATION f10q0918ex31-1_relmadatherap.htm EX-31.1 20281
7 CERTIFICATION f10q0918ex31-2_relmadatherap.htm EX-31.2 20568
8 CERTIFICATION f10q0918ex32-1_relmadatherap.htm EX-32.1 8375
9 CERTIFICATION f10q0918ex32-2_relmadatherap.htm EX-32.2 8390
  Complete submission text file 0001213900-18-015476.txt   3410345

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE rlmd-20180930.xml EX-101.INS 406862
11 XBRL SCHEMA FILE rlmd-20180930.xsd EX-101.SCH 37688
12 XBRL CALCULATION FILE rlmd-20180930_cal.xml EX-101.CAL 41979
13 XBRL DEFINITION FILE rlmd-20180930_def.xml EX-101.DEF 157926
14 XBRL LABEL FILE rlmd-20180930_lab.xml EX-101.LAB 285844
15 XBRL PRESENTATION FILE rlmd-20180930_pre.xml EX-101.PRE 219720
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 212-547-9591
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55347 | Film No.: 181177650
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1